Takahara Y, Sudou Y, Nakano H, Niizuma Y, Sato T, Ishikawa H, Nakajima N
Division of Cardiovascular Surgery, Funabashi Municipal Medical Center, 1-21-1 Kanasugi, Funabashi, Chiba 273-8588, Japan.
Jpn J Thorac Cardiovasc Surg. 2001 Feb;49(2):103-7. doi: 10.1007/BF02912125.
For patients diagnosed with combined thoracic aortic aneurysms and cardiac lesions, we conduct a 1-stage operation for ascending and aortic arch grafting. We studied surgical outcome comparatively with patients undergoing aortic grafting alone. For descending and thoracoabdominal aortic grafting, we choose a 2-stage operation.
Subjects were 80 patients undergoing ascending and aortic arch aneurysm repair between June 1994 and March 1999. Group 1 consisted of 30 undergoing simultaneous cardiac repair. Concomitant cardiac procedures involved 21 valvular, 5 coronary arterial, and 4 valvular and coronary arterial surgeries. Group 2 consisted of 50 undergoing aortic grafting alone. We used crystalloid cardioplegia and additional antegrade continuous cold-blood coronary perfusion in Group 1, and crystalloid cardioplegia alone in Group 2.
Hospital mortality was 10% in Group 1 and 2% in Group 2. Surgery length, cardiopulmonary bypass time, and aortic cross-clamping time in Group 1 were significantly longer than Group 2. Myocardial ischemic time did not differ significantly. Postoperative ICU stay, mechanical ventilation time and catecholamine support time did not differ significantly. Actuarial survival was 66.9 +/- 13.1% at 52 months in Group 1 and 87.2 +/- 4.8% at 57 months in Group 2 (p = 0.2918).
Simultaneous cardiac repair and ascending and aortic arch aneurysm repair were conducted using continuous cold-blood coronary perfusion. Hospital mortality and mid-term survival did not differ significantly between groups.
对于诊断为合并胸主动脉瘤和心脏病变的患者,我们对升主动脉和主动脉弓进行一期移植手术。我们将其手术结果与单纯接受主动脉移植的患者进行了比较。对于降主动脉和胸腹主动脉移植,我们选择二期手术。
研究对象为于1994年6月至1999年3月期间接受升主动脉和主动脉弓动脉瘤修复的80例患者。第1组由30例同时进行心脏修复的患者组成。同期心脏手术包括21例瓣膜手术、5例冠状动脉手术以及4例瓣膜和冠状动脉联合手术。第2组由50例单纯接受主动脉移植的患者组成。第1组使用晶体心脏停搏液并额外进行顺行持续冷血冠状动脉灌注,第2组仅使用晶体心脏停搏液。
第1组的医院死亡率为10%,第2组为2%。第1组的手术时长、体外循环时间和主动脉阻断时间显著长于第2组。心肌缺血时间无显著差异。术后重症监护病房停留时间、机械通气时间和儿茶酚胺支持时间无显著差异。第1组在52个月时的精算生存率为66.9±13.1%,第2组在57个月时为87.2±4.8%(p = 0.2918)。
采用持续冷血冠状动脉灌注同时进行心脏修复以及升主动脉和主动脉弓动脉瘤修复。两组之间的医院死亡率和中期生存率无显著差异。